Skip to Main

Olivier Wierzba is a core member of The Boston Consulting Group’s Corporate Development and Health Care practices. He leads BCG’s global work in corporate strategy and mergers and acquisitions within the biopharma sector. He worked for several years in BCG’s New York office.

Since joining BCG in 1998, Olivier has worked with numerous companies in the health care industry on issues related to corporate finance, M&A, transformation, and integration.. He is particularly knowledgeable about corporate transactions, scenario planning, and strategy development.

Olivier’s project experience includes supporting M&A transactions at all stages for biopharma, biotech, and private equity companies, helping companies through the process of postmerger integration; and leading large-scale transformation efforts.

Prior to joining BCG, Olivier worked as an investment banking analyst with Lehman Brothers in London.

AREAS OF EXPERTISE

EDUCATION

  • Master’s degree, finance, Ecole Supérieure de Commerce de Paris

Publications and Videos

COVID-19 Opens a New Era for Real-World Evidence in Pharma-rectangle.jpg

COVID-19 Opens a New Era for Real-World Evidence in Pharma

To capture the opportunities, companies must build a fit-for-purpose strategy while proactively helping to shape the regulatory environment.
" "

Five Ways Men Can Improve Gender Diversity at Work

Rather than walling off gender diversity as a women-only issue, companies need to get men at all levels actively involved. Several strategies can help.